These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 2518523)
21. [Results of surgical treatment of the "minimal" forms of breast cancer]. Semiglazov VF; Orlov AA Vestn Khir Im I I Grek; 1983 Mar; 130(3):47-51. PubMed ID: 6857957 [TBL] [Abstract][Full Text] [Related]
22. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335 [TBL] [Abstract][Full Text] [Related]
23. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Boyages J; Delaney G; Taylor R Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735 [TBL] [Abstract][Full Text] [Related]
24. [Patey's radical mastectomy in combined treatment of breast cancer]. Datsenko VS; Rozanov IB; Sukhoveev PN; Vinogradov LI Khirurgiia (Mosk); 1989 Dec; (12):81-5. PubMed ID: 2625904 [TBL] [Abstract][Full Text] [Related]
25. Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials. Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J Radiother Oncol; 2006 May; 79(2):147-55. PubMed ID: 16647152 [TBL] [Abstract][Full Text] [Related]
26. Locoregional recurrence in breast carcinoma patients. Yildirim E Eur J Surg Oncol; 2009 Mar; 35(3):258-63. PubMed ID: 18644692 [TBL] [Abstract][Full Text] [Related]
27. [Anatomo-surgical considerations on the indications and technic of Patey's radical mastectomy]. Nemeth A; Roseano M Chir Ital; 1981 Aug; 33(4):823-36. PubMed ID: 7034981 [TBL] [Abstract][Full Text] [Related]
28. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy. Harris EE; Hwang WT; Seyednejad F; Solin LJ Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083 [TBL] [Abstract][Full Text] [Related]
29. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825 [TBL] [Abstract][Full Text] [Related]
30. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064 [TBL] [Abstract][Full Text] [Related]
31. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?]. Willner J; Kiricuta IC; Kölbl O Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301 [TBL] [Abstract][Full Text] [Related]
32. [Risk of locally-advanced recurrences of breast cancer following organ-saving surgery]. Gurbanov SS; Matsko DE; Kanaev SV; Semiglazov VF Vopr Onkol; 2009; 55(1):33-7. PubMed ID: 19435196 [TBL] [Abstract][Full Text] [Related]
33. A comparative study of subcutaneous mastectomy with radical mastectomy. Horiguchi J; Iino JHY ; Takei H; Koibuchi Y; Iijima K; Ikeda F; Ochiai R; Uchida K; Yoshida M; Yokoe T; Morishita Y Anticancer Res; 2001; 21(4B):2963-7. PubMed ID: 11712794 [TBL] [Abstract][Full Text] [Related]
34. [Incidence of local recurrence after breast preserving surgery]. Garami Z; Szluha K; Kósa C; Fülöp B; Lukács G Magy Seb; 2006 Jun; 59(3):179-83. PubMed ID: 16937793 [TBL] [Abstract][Full Text] [Related]
35. Recurrence of node-negative breast cancer in patients treated in a community hospital. Hahneman BM; Thompson SJ; Babcock WH; Salters S J S C Med Assoc; 1989 Dec; 85(12):560-4. PubMed ID: 2615325 [No Abstract] [Full Text] [Related]
36. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262 [TBL] [Abstract][Full Text] [Related]
37. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer. Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100 [TBL] [Abstract][Full Text] [Related]
38. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189 [TBL] [Abstract][Full Text] [Related]
39. Breast conservation in patients with multiple ipsilateral synchronous cancers. Kaplan J; Giron G; Tartter PI; Bleiweiss IJ; Estabrook A; Smith SR J Am Coll Surg; 2003 Nov; 197(5):726-9. PubMed ID: 14585405 [TBL] [Abstract][Full Text] [Related]
40. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer. Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]